A Study of PCSK9 Inhibitor AK102 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
Conditions
- Heterozygous Familial Hypercholesterolemia
Interventions
- DRUG: AK102
- DRUG: Placebo
- DRUG: Statins and/or Ezetimibe
Sponsor
Akeso
Collaborators